Engine No. 1 LLC Gilead Sciences, Inc. Transaction History

Engine No. 1 LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $497,243 - $623,099	-8,585 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $118,081 - $134,024	1,820 Added 26.9%	8,585 $623,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $187,095 - $201,854	2,764 Added 69.08%	6,765 $473,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $253,943 - $277,469	4,001 New	4,001 $276,000

1,962

995M

10.5M

9.85M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $123B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Engine No. 1 LLC with notifications on news.